Jennifer J. Rhodes - 14 Jun 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role: Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
Signature: /s/ Jennifer J. Rhodes
Issuer symbol: ELTX
Transactions as of: 14 Jun 2021
Net transactions value: -$5,666
Form type: 4
Filing time: 16 Jun 2021, 16:06:24 UTC
Previous filing: 18 May 2021
Next filing: 20 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELTX	Common Stock	Sale	$5,666	-427	-1.3%	$13.27	33,020	14 Jun 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") granted by the Issuer.

Remarks:

Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary